Navigation Links
'Headache' Publication Describes Potential Mechanistic Rationale for LEVADEX(TM) Favorable Adverse Event Profile
Date:9/22/2009

not stimulate receptors thought to be responsible for the adverse event profile characteristics of IV DHE.

"We believe that these receptor studies could explain the lower adverse event incidence seen in clinical trials with LEVADEX to date because of the novel pharmacokinetic profile of our formulation and delivery method," said Shashidhar H. Kori, M.D., vice president of clinical development and medical affairs of MAP Pharmaceuticals. "In Phase 2 and Phase 3 clinical trials, LEVADEX has shown the potential to provide rapid and sustained relief of migraine symptoms and good tolerability for patients. Based on our receptor studies and clinical trials to date, we believe that LEVADEX has the potential to provide a treatment alternative for the many patients who suffer from the debilitating effects of migraine."

About LEVADEX(TM)

LEVADEX orally inhaled migraine therapy is a novel migraine therapy in Phase 3 development. Patients administer LEVADEX themselves using the company's proprietary TEMPO inhaler. LEVADEX has been designed to be differentiated from existing migraine treatments. It is a novel formulation of dihydroergotamine (DHE), a drug used intravenously in clinical settings to effectively and safely treat migraines. Based on clinical results, the company believes that LEVADEX has the potential to provide both fast onset of action and sustained pain relief and other migraine symptom relief in an easy-to-use and non-invasive at-home therapy.

LEVADEX is designed to incorporate the multiple beneficial mechanisms of action that allow DHE to block initiation of migraine, limit pain, reduce inflammation and stop a migraine at any point in the migraine cycle. Based on research to date, including the FREEDOM-301 trial, the company believes the unique pharmacokinetic profile of LEVADEX has the potential to effectively treat migraines, while minimizing the side effects commonly seen with DHE an
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. SAGE to publish leading international headache journal Cephalalgia
2. High-Octane Caffeine May Trigger Headaches
3. Children with headache
4. Surgery for Neck Pain May Also Relieve Headaches
5. Jefferson Headache Center study shows novel, orally inhaled migraine therapy effective
6. Neck surgery for cervical spine disorders found to alleviate associated headaches
7. Neck Surgery for Cervical Spine Disorders Found to Alleviate Associated Headaches
8. Many Kids Outgrow Chronic Headaches
9. Viles & Beckman, LLC: Stop Your Headache NOT Your Liver
10. EHE International Supports the National Headache Foundation
11. New Online Tool Helps People With Headache Take Control, Get Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... HealthDay Reporter , WEDNESDAY, Nov. 26, ... acquire a second language, new research suggests. But anyone who ... a brain boost, the small study finds. The ... co-author Ping Li, co-director of the Center for Brain, Behavior ... interesting, Li said, that "the brain networks of the more ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 In order to ... from Sharpes, Fla., designed an easy way to avoid touching ... , He then created a prototype of the patent-pending Toilet ... lower a toilet seat and/or lid in a more sanitary ... the spread of germs. Overall, it promotes good hygiene and ...
(Date:11/27/2014)... York, New York (PRWEB) November 27, 2014 ... of individuals who were allegedly injured by the medication ... where a federal litigation is looking ahead to a ... , According to a Scheduling Order issued earlier this ... place on December 16th at 10:00 a.m. Items likely ...
(Date:11/27/2014)... “LAB.C” was featured on NewsWatch as part of its monthly ... available to consumers. Mallory Sofastaii, a technology expert and reporter ... with viewers the company offers a cable case, iBed, and ... portability and functionality. A unique mobile company at IFA ... 5S has a portable USB charger built in. The certified ...
(Date:11/27/2014)... Burnsville MN (PRWEB) November 27, 2014 ... manufacturer of office ergonomics equipment , has announced ... partnership with Commercial Office Environments. The partnership will ... for office furnishings location. , In addition to ... the new dealer partnership promotes HealthPostures' products with ...
Breaking Medicine News(10 mins):Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2
... of compounds commonly found in garlic may not only ... they inhibit the infection appears to be similar to ... from the University of Toronto report these findings at ... Tropical Medicine and Hygiene in Atlanta.// ,The compounds ...
... to suffer brain cell damage from long-term use of the ... if they stop taking the drug. Studies have shown that ... damage nerve endings that release serotonin, a brain chemical that ... to damage brain cells that transmit nerve signals. // ...
... drug simvastatin with the B vitamin niacin lowers the ... up to 90% in some patients. The study of ... (good) cholesterol showed that 3 years of the combo ... and significantly lowered heart complications compared with an inactive ...
... of “lefties” tend to make a person better at ... in the affirmative. This recent reasearch is reported in the ... of the University of Toledo in Ohio, studied memory ... don’t have to be personally left-handed to share a ...
... by the hypothalamus, the area of the brain that ... may underlie chronic migraines. The findings provide hope for ... suffer from the debilitating headaches, since drugs that regulate ... the headaches, according to Dr. Mario Peres, the study's ...
... do not realise that future patients are more likely to ... - or any other disease - unless there are clinical ... in California gathered views from more than 200 patients involved ... 60 per cent realised they might not get any direct ...
Cached Medicine News:Health News:Simvastatin Plus Niacin May Lower Heart Risks 2
(Date:11/26/2014)... , November 26, 2014 Investor-Edge ... VVUS ), Horizon Pharma PLC (NASDAQ: ... and Johnson (NYSE: JNJ ), and Theravance Inc. ... companies can be accessed at: http://investor-edge.com/register . ... 4,758.25, up 0.07%, the Dow Jones Industrial Average edged 0.02% ...
(Date:11/26/2014)... 26, 2014 A hernia is condition ... protrudes through the wall of a weak muscle area. Obesity, ... are some of the causes of hernias. There are several ... incisional. An inguinal hernia is when part of the abdominal ... found in the area of the umbilicus. A hiatal hernia ...
(Date:11/26/2014)... 2014  Aridis Pharmaceuticals, Inc., a biopharmaceutical company ... infectious diseases, announced today the addition of ... opinion leader in the areas of pneumonia and ... Founder and Chief Executive Officer, Vu ... extensive experience investigating bacterial toxins and key mechanisms ...
Breaking Medicine Technology:Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3
... NovaRx Corporation announced today the appointment of Norrie ... Chief Operating Officer. Dr. Russell brings to the ... and a long history of success driving innovation in ... leading entrepreneurial biotechnology companies developing pioneering new technologies. ...
... 3 Sangamo BioSciences, Inc.,(Nasdaq: SGMO ) ... milestones,achieved in 2008 and preview objectives for 2009 during ... New York City today. , David Smoller, ... discuss the progress and expected potential of the,two companies, ...
Cached Medicine Technology:NovaRx Appoints Industry Veteran as President and COO 2NovaRx Appoints Industry Veteran as President and COO 3Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 2Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 3Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 4Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 5Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 6
Wright-Giemsa Stain Solutions...
... For fast, single-solution staining, Hema-Quik ... slides into stain solution for ... to deionized water for five ... second time by dipping quickly ...
... for staining of peripheral blood smears ... stain formulations still in use today. ... of Giemsa stain, although eosinophillic granules ... granules and nuclear chromatin stain a ...
This stain is the McNeal formula and can be substituted for Wright Stain solution....
Medicine Products: